| ID | Sequence | Length | GC content |
|---|---|---|---|
| GCAGGUUCCGGGCUGCUUAGGUUGGCACCGGUCCGUGGUCCCCGGGGGC… | 1073 nt | 0.5508 | |
| GCAGGUUCCGGGCUGCUUAGGUUGGCACCGGUCCGUGGUCCCCGGGGGC… | 1588 nt | 0.5359 | |
| GCAGGUUCCGGGCUGCUUAGGUUGGCACCGGUCCGUGGUCCCCGGGGGC… | 959 nt | 0.5485 | |
| GCAGGUUCCGGGCUGCUUAGGUUGGCACCGGUCCGUGGUCCCCGGGGGC… | 1355 nt | 0.5638 |
This gene encodes a member of the thioredoxin family of enzymes. It is a cytosolic and ubiquitously expressed flavoprotein that catalyzes the two-electron reduction of quinone substrates and uses dihydronicotinamide riboside as a reducing coenzyme. Mutations in this gene have been associated with neurodegenerative diseases and several cancers. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2014]
A study in humans using proteomics and RNA sequencing on peripheral blood samples from sepsis patients and healthy volunteers identified the NQO2 as a potential diagnostic biomarker for sepsis, where it was found to have a consistent mRNA and protein expression pattern and was lowly expressed in the sepsis group based on RNA sequencing data [Wang et al. DOI:10.2147/IDR.S380137].